Press release
Leading mid-sized contract manufacturer Losan Pharma introduces Werum’s PAS-X for production of solid dosage forms
Leading mid-sized contract manufacturer Losan Pharma introduces Werum’s PAS-X for production of solid dosage formsImplementation in the main plant in Neuenburg am Rhein, Germany / Full-scope MES including warehouse management / Fully integrated Track & Trace
Lüneburg, Germany, August 11, 2015 – Losan Pharma is going to introduce the latest version of Werum’s PAS-X MES in their main plant in Neuenburg am Rhein, Germany. The medium-sized company specializes in contract research and manufacturing (CMO) of innovative solid dosage forms and has many international pharma and biotech customers. Werum’s PAS-X meets the various requirements of a CMO company with a differing customer structure.
PAS-X will be implemented in several stages as a full-scope MES out of the box and it will be interfaced with the Infor Blending ERP system. Once PAS-X is fully implemented, it comprises e.g. a warehouse management system and a fully integrated Track & Trace system to prevent counterfeiting.
“The integrated Track & Trace functionality ensures a consistent flow of information from the ERP to the automation level. So we do not need an additional third-party product for serialization,” says Dr. Marco Klingele, Head of Administration, Losan Pharma GmbH. “PAS-X will help us to significantly increase the efficiency and quality of our processes and provide our customers with even better products in an even shorter time.”
Werum IT Solutions is the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical and biopharmaceutical industries. Its out-of-the-box PAS-X software product is run by 17 of the world’s top 30 pharmaceutical and biotech companies but also by many mid-sized manufacturers. Werum’s manufacturing IT solutions help pharma manufacturers to increase efficiency, improve productivity, and meet regulatory requirements. Founded in 1969, the IT company employs about 420 people at its headquarters in Lüneburg, Germany, and at ten other locations in Europe, America and Asia.
Werum is part of Medipak Systems, the Pharma Systems business area of the international Körber technology group. Körber unites worldwide nearly 12,000 professionals in industry-leading companies, achieving annual earnings of more than 2.3 billion Euros. As a Medipak Systems company, Werum provides integrated IT solutions for all phases of pharmaceutical and biopharmaceutical production – including process development, commercial production, and packaging as well as track & trace serialization.
For more information take a look at our website www.werum.com.
Dirk Ebbecke
Director Corporate Communications
Werum IT Solutions GmbH
Wulf-Werum-Str. 3
21337 Lüneburg, Germany
Tel. +49 4131 8900-689
Fax +49 4131 8900-20
dirk.ebbecke@werum.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading mid-sized contract manufacturer Losan Pharma introduces Werum’s PAS-X for production of solid dosage forms here
News-ID: 314547 • Views: …
More Releases from Werum IT Solutions GmbH

Werum IT Solutions introduces new service for the cost-effective, high-quality a …
Werum IT Solutions introduces new service for the cost-effective, high-quality and large-scale MBR creation
“Design as a Service” offers the customer-specific creation of MBRs and the efficient operation of Werum’s PAS-X manufacturing execution system
Lüneburg, Germany, September 23, 2015 – Development of new drugs, process harmonization and standardization or efficient operation of manufacturing execution systems (MES) – pharmaceutical and biopharmaceutical companies face major challenges to remain competitive. In this regard, electronic master…
Boosting paperless pharma manufacturing in India: strategic partnership of Werum …
Werum and Sarla to partner for delivering MES projects in India / Multinationals and local pharma companies will benefit from the number one global pharma MES solution and smooth integration of the automation level
Lüneburg, Germany, September 15, 2015 – Werum IT Solutions, the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical and biopharmaceutical industries, and Sarla Technologies jointly announced a memorandum of understanding…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…